EF-M2 (Immutalon)

EF-M2 · S.LAB (SOLOWAYS)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EF-M2 (Immutalon), covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: EF-M2 (Immutalon) Multiple Ascending Dose Study in Moderate-to-Severe Rheumatoid Arthritis [Phase 1, Phase 2]